|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Bite, black widow spider |
|
Deficiency, calcium |
|
Dermatitis herpetiformis |
|
Dermatosis, exudative |
|
Hyperkalemia |
|
Hypocalcemia |
|
Hypocalcemia, secondary to pregnancy |
|
Hypoparathyroidism |
|
Osteomalacia |
|
Pruritus, secondary to drug reactions |
|
Purpura, nonthrombocytopenic |
|
Rickets, adjunct |
|
Tetany, hypocalcemic |
|
Toxicity, lead |
|
Toxicity, magnesium |
| |
|
|
SIDE EFFECTS:
|
|
anorexia |
|
AV block |
|
cardiac arrest |
|
confusion |
|
constipation |
|
dizziness |
|
drowsiness |
|
flushing |
|
hypercalcemia |
|
hypertension |
|
hypotension |
|
injection site reaction |
|
milk-alkali syndrome |
|
nausea/vomiting |
|
nephrolithiasis |
|
polyuria |
|
premature ventricular contractions (PVCs) |
|
pruritus |
|
sinus bradycardia |
|
syncope |
|
tissue necrosis |
|
ventricular fibrillation |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
breast-feeding |
|
cardiac arrhythmias |
|
dehydration |
|
diarrhea |
|
hyperphosphatemia |
|
hypoparathyroidism |
|
pregnancy |
|
sarcoidosis |
|
ventricular fibrillation |
|
|
ADULT DOSE:
|
|
Hypocalemia (prophylaxis)-Intravenous infusion, as part of total parenteral nutrition solutions, the specific amount determined by individual patient need.
Hypocalcemia (treatment) or
Electrolyte replenisher-Intravenous, 970 mg (94.7 mg of calcium ion), administered slowly at a rate not to exceed 5 mL (47.5 mg of calcium ion) a minute. The dosage may be repeated, if necessary, until tetany is controlled.
Note: For use in cases such as hungry bones syndrome, some clinicians recommend that calcium gluconate be diluted in isotonic solution and given by continuous intravenous infusion at a dosage of 0.5 to 1 mg per minute (up to 2 or more mg per minute). The rate and/or concentration can be adjusted until oral calcium supplements can be given.
Antihyperkalemic-Intravenous, 1 to 2 grams (94.7 to 189 mg of calcium ion), administered slowly at a rate not to exceed 5 mL (47.5 mg of calcium ion) a minute, the dosage being titrated and adjusted by constant monitoring of ECG changes during administration.
[Antihypermagnesemic]-Intravenous, 1 to 2 grams (94.7 to 189 mg of calcium ion), administered at a rate not to exceed 5 mL (47.5 mg of calcium ion) a minute. |
|
MAXIMUM ADULT DOSE:
|
|
15 grams (1.42 gram of calcium ion) a day.
|
|
PEDIATRIC DOSE:
|
|
Hypocalcemia (prophylaxis)-Intravenous infusion, as part of total parenteral nutrition solutions, the specific amount determined by individual patient need.
Hypocalcemia (treatment)-Intravenous, 200 to 500 mg (19.5 to 48.8 mg of calcium ion) as a single dose, administered slowly at a rate not to exceed 5 mL (47.5 mg of calcium ion) a minute, repeated if necessary until tetany is controlled.
Exchange transfusions in newborns-Intravenous, 97 mg (9.5 mg of calcium ion) administered after every 100 mL of citrated blood exchanged. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|